back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-09 12:17 Tx date 2025-01-01 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
58 - Expiration of rights
|
-120,000 vol |
513,000 | |
| Filed 2026-06-09 12:17 Tx date 2024-01-01 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
58 - Expiration of rights
|
-150,000 vol |
300,000 | |
| Filed 2026-06-09 12:15 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-513,000 vol |
0 | |
| Filed 2026-06-09 12:14 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-997,771 vol |
0 | |
| Filed 2026-06-08 23:33 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-26,240
-32,800 vol $0.80 each |
0 | |
| Filed 2026-06-08 23:33 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: Spouse's TFSA (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-39,680
-49,600 vol $0.80 each |
0 | |
| Filed 2026-06-08 21:55 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-527,480.80
-659,351 vol $0.80 each |
0 | |
| Filed 2024-12-28 22:59 Tx date 2024-12-23 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
$183,150
+333,000 vol $0.55 each |
783,000 | |
| Filed 2024-01-02 22:43 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
$82,800
+180,000 vol $0.46 each |
450,000 | |
| Filed 2024-01-02 22:41 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$23,998
+52,171 vol $0.46 each |
997,771 | |
| Filed 2023-12-29 15:56 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: Spouse's TFSA (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,644
+15,100 vol $0.44 each |
49,600 | |
| Filed 2023-12-29 15:55 Tx date 2023-12-27 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: Spouse's TFSA (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,870
+34,500 vol $0.46 each |
34,500 | |
| Filed 2023-12-29 15:54 Tx date 2017-04-17 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: Spouse's TFSA (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-12-29 15:47 Tx date 2023-12-27 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,030
+21,000 vol $0.43 each |
32,800 | |
| Filed 2023-12-29 15:40 Tx date 2023-12-27 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,350
+10,000 vol $0.435 each |
659,351 | |
| Filed 2023-09-05 12:52 Tx date 2023-08-31 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$34,848
+52,800 vol $0.66 each |
945,600 | |
| Filed 2023-06-25 22:55 Tx date 2023-06-20 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$34,320
+52,800 vol $0.65 each |
892,800 | |
| Filed 2022-01-05 11:49 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+120,000 vol |
270,000 | |
| Filed 2022-01-05 11:13 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+120,000 vol |
840,000 | |
| Filed 2021-12-17 16:47 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$310.00
+500 vol $0.62 each |
11,800 |